MedTrace Logo

Mandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects

NCT05467579 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-07-20

No results posted yet for this study

Summary

There is currently no information on how mandibular advancement therapy could influence three-dimensionally the condylar and mandibular morphology in growing patients affected by Juvenile Idiopathic Arthritis (JIA). Therefore, the aim is to assess the three-dimensional morphological mandibular changes produced by the Invisalign® Mandibular Advancement (MA) (Align Technology, San José, CA, USA) in growing subjects affected by juvenile idiopathic arthritis with unilateral and bilateral JIA and to compare them with not-JIA control subjects

Conditions

  • Juvenile Idiopathic Arthritis
  • Malocclusion, Angle Class II

Interventions

DEVICE

Device: orthodontic - mandibular advancement clear aligner

Intervention orthodontic - mandibular advancement: mandibular retrognathia correction with a mandibular advancement using a step-wise approach with clear aligner.

Sponsors & Collaborators

  • University of Milan - Prof. Maspero Cinzia

    collaborator UNKNOWN

  • University of Milan - Dr. Abate Andrea

    collaborator UNKNOWN

  • University of Genova

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-01-01
Completion
2025-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05467579 on ClinicalTrials.gov